Skip to main content

Table 5 Some quotes from focus groups on participants’ opinions about key features of drug information

From: Knowledge transfer: what drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy

Feature Quotes
Reliability “… information is reliable when it is transmitted by an authoritative source …”
“… world-famous opinion leaders … big shots, who have great experience and have done pivotal studies … when they talk, we just listen …”
(in scientific research) “… the presence of authoritative and independent researchers is important …”
(in scientific journals) “…drugs can be evaluated by researchers outside the sponsor company …”
“… if the goal is improving patient care I trust it … I don’t if we talk about piddling …
Completeness “… it’s necessary to look at everything … let’s not just look at positive data … every drug has weaknesses and knowing about them would bring added value to info …”
“ … comparative information to understand which drug is better for one patient and which for another one …”
“… if you don’t relate information to everyday practice, what is the use of it?…”
Usability “… easily accessible, through the web … in Pubmed … possibly free of charge …”
“… not too detailed … or pompous … it should be strict to the point … providing hints that I can deepen on my own …”
“… when I ask for information, drug reps bring it to me the day after …”
“… I like information targeting specific needs … personalized …”
(guidelines refer to populations) “different from your own patients … in different countries they say different things … you cannot read them in one minute … they are huge …”
Exchange “… I would like talking with colleagues … they may have more experience with specific types of patients … sometimes I don’t know how to manage them… I’d like getting help to choose the right drug for each patient …”
“… people with field experience … with knowledge that you can’t find anywhere …”
“… information-sharing is really enriching … it creates synergy … it is quick, maybe directly at bedside … it refers to real situations, unlike statistics in congresses …”
“… let’s talk about real cases … there is a wide array of patients … they are different from theory … we also cure immigrants …”
Transparency – conflicts of interest (drug reps) “… you know which side they are on and they are honest in admitting that …
(sponsored symposia) “… it is clear who is behind them … knowing it, we don’t have any problem …”